
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 627 |
| Issued Applications | 267 |
| Pending Applications | 54 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9762566
[patent_doc_number] => 08846891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)'
[patent_app_type] => utility
[patent_app_number] => 13/060533
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26589
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060533
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/060533 | Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1) | Aug 6, 2009 | Issued |
Array
(
[id] => 6142241
[patent_doc_number] => 20110129496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Use of mTOR Inhibitors to Enhance T Cell Immune Responses'
[patent_app_type] => utility
[patent_app_number] => 13/057057
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 26437
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129496.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057057
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057057 | Use of mTOR inhibitors to enhance T cell immune responses | Aug 4, 2009 | Issued |
Array
(
[id] => 7580312
[patent_doc_number] => 20110294195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a'
[patent_app_type] => utility
[patent_app_number] => 13/059137
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17041
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294195.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059137
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059137 | Efficient cell culture system for hepatitis C virus genotype 7a | Jul 30, 2009 | Issued |
Array
(
[id] => 7580311
[patent_doc_number] => 20110294194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 2B'
[patent_app_type] => utility
[patent_app_number] => 13/059130
[patent_app_country] => US
[patent_app_date] => 2009-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16792
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294194.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059130
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059130 | Efficient cell culture system for hepatitis C virus genotype 2B | Jul 23, 2009 | Issued |
Array
(
[id] => 5993603
[patent_doc_number] => 20110015256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'DELIVERY OF RESTRICTION ENDONUCLEASES TO TREAT HIV, CANCER, AND OTHER MEDICAL CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/504279
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6587
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015256.pdf
[firstpage_image] =>[orig_patent_app_number] => 12504279
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/504279 | DELIVERY OF RESTRICTION ENDONUCLEASES TO TREAT HIV, CANCER, AND OTHER MEDICAL CONDITIONS | Jul 15, 2009 | Abandoned |
Array
(
[id] => 6530985
[patent_doc_number] => 20100221264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein'
[patent_app_type] => utility
[patent_app_number] => 12/498157
[patent_app_country] => US
[patent_app_date] => 2009-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19047
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221264.pdf
[firstpage_image] =>[orig_patent_app_number] => 12498157
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/498157 | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein | Jul 5, 2009 | Issued |
Array
(
[id] => 7776529
[patent_doc_number] => 20120039984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'GLYCOPEPTIDE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/002180
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 49470
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20120039984.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002180
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002180 | GLYCOPEPTIDE AND USES THEREOF | Jul 1, 2009 | Abandoned |
Array
(
[id] => 5315963
[patent_doc_number] => 20090280561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'FUSION PROTEIN OF HIV REGULATORY/ACCESSORY PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/490424
[patent_app_country] => US
[patent_app_date] => 2009-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7588
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280561.pdf
[firstpage_image] =>[orig_patent_app_number] => 12490424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/490424 | Fusion protein of HIV regulatory/accessory proteins | Jun 23, 2009 | Issued |
Array
(
[id] => 6280654
[patent_doc_number] => 20100119551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response'
[patent_app_type] => utility
[patent_app_number] => 12/456699
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19567
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119551.pdf
[firstpage_image] =>[orig_patent_app_number] => 12456699
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/456699 | Methods and reagents for vaccination which generate a CD8 T cell immune response | Jun 18, 2009 | Abandoned |
Array
(
[id] => 6536383
[patent_doc_number] => 20100124553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-20
[patent_title] => 'Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/486733
[patent_app_country] => US
[patent_app_date] => 2009-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6475
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20100124553.pdf
[firstpage_image] =>[orig_patent_app_number] => 12486733
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/486733 | Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy | Jun 16, 2009 | Abandoned |
Array
(
[id] => 8421568
[patent_doc_number] => 08278056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Detection of early stages and late stages HPV infection'
[patent_app_type] => utility
[patent_app_number] => 12/456076
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 56
[patent_no_of_words] => 25703
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12456076
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/456076 | Detection of early stages and late stages HPV infection | Jun 9, 2009 | Issued |
Array
(
[id] => 6348269
[patent_doc_number] => 20100021427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV'
[patent_app_type] => utility
[patent_app_number] => 12/474702
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11843
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021427.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474702
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474702 | Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV | May 28, 2009 | Abandoned |
Array
(
[id] => 5304122
[patent_doc_number] => 20090298774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Bifunctional Molecules for Inhibiting HIV Entry'
[patent_app_type] => utility
[patent_app_number] => 12/474105
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9048
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298774.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474105
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474105 | Bifunctional molecules for inhibiting HIV entry | May 27, 2009 | Issued |
Array
(
[id] => 5458191
[patent_doc_number] => 20090258343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 Ligand/CD154, A CD4+ T cell equivalent and the simultaneous detection of HIV infection via HIV antibody detection'
[patent_app_type] => utility
[patent_app_number] => 12/454951
[patent_app_country] => US
[patent_app_date] => 2009-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10472
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258343.pdf
[firstpage_image] =>[orig_patent_app_number] => 12454951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454951 | Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 Ligand/CD154, A CD4+ T cell equivalent and the simultaneous detection of HIV infection via HIV antibody detection | May 26, 2009 | Abandoned |
Array
(
[id] => 5533059
[patent_doc_number] => 20090232847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Immunogenic compositions'
[patent_app_type] => utility
[patent_app_number] => 12/471772
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 14782
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232847.pdf
[firstpage_image] =>[orig_patent_app_number] => 12471772
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/471772 | Immunogenic compositions | May 25, 2009 | Abandoned |
Array
(
[id] => 5375100
[patent_doc_number] => 20090312661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'DEVICE FOR DETERMINING A CONDITION OF FLOW IN A RESPIRATION SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/469907
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 5395
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312661.pdf
[firstpage_image] =>[orig_patent_app_number] => 12469907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/469907 | Device for determining a condition of flow in a respiration system | May 20, 2009 | Issued |
Array
(
[id] => 8737334
[patent_doc_number] => 08409096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-02
[patent_title] => 'Breathing circuit with embedded acoustic reflectometer'
[patent_app_type] => utility
[patent_app_number] => 12/469492
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 5203
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12469492
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/469492 | Breathing circuit with embedded acoustic reflectometer | May 19, 2009 | Issued |
Array
(
[id] => 5374185
[patent_doc_number] => 20090311746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'INTERGENIC REGIONS AS INSERTION SITES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA (MVA)'
[patent_app_type] => utility
[patent_app_number] => 12/468120
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 10587
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311746.pdf
[firstpage_image] =>[orig_patent_app_number] => 12468120
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/468120 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | May 18, 2009 | Issued |
Array
(
[id] => 7502323
[patent_doc_number] => 08034354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-11
[patent_title] => 'Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)'
[patent_app_type] => utility
[patent_app_number] => 12/468127
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 10669
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/034/08034354.pdf
[firstpage_image] =>[orig_patent_app_number] => 12468127
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/468127 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | May 18, 2009 | Issued |
Array
(
[id] => 5464432
[patent_doc_number] => 20090324632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response'
[patent_app_type] => utility
[patent_app_number] => 12/454385
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19595
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324632.pdf
[firstpage_image] =>[orig_patent_app_number] => 12454385
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454385 | Methods and reagents for vaccination which generate a CD8 T cell immune response | May 14, 2009 | Abandoned |